首页> 外文期刊>American Journal of Epidemiology >X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
【24h】

X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.

机译:X射线修复交叉互补第1组(XRCC1)遗传多态性与胃癌风险:HuGE审查和荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

The authors performed a systematic review and meta-analysis of associations of the x-ray repair cross-complementing 1 gene (XRCC1) single nucleotide polymorphisms (SNPs) Arg194Trp, Arg280His, and Arg399Gln with gastric cancer risk, based on eligible studies retrieved from electronic databases for the period January 2000-December 2009. Ultimately, 12, 6, and 3 studies were found to be eligible for meta-analyses of Arg399Gln, Arg194Trp, and Arg280His, respectively. Regrouping was adopted in accordance with the most probably appropriate genetic models. Potential sources of heterogeneity were sought out. For overall gastric cancer, the pooled odds ratios for Arg399Gln, Arg194Trp, and Arg280His were 1.04 (95% confidence interval (CI): 0.90, 1.20; P = 0.572), 0.83 (95% CI: 0.68, 1.01; P = 0.059), and 1.18 (95% CI: 0.92, 1.50; P = 0.194), respectively. After stratification of the Arg399Gln SNP data by anatomic type (cardia vs. noncardia), the pooled odds ratio was 1.07 (95% CI: 0.84, 1.37; P = 0.568). The authors conclude that the 3 SNPs evaluated are not associated with risk of gastric cancer. The Arg399Gln SNP is not associated with the cardia type of gastric cancer. Evidently, the heterogeneity regarding the Arg399Gln SNP across studies is not explained by ethnicity, genotyping technique, sample size, or date of publication.
机译:作者根据电子检索的合格研究,对X射线修复交叉互补1基因(XRCC1)单核苷酸多态性(SNP)Arg194Trp,Arg280His和Arg399Gln与胃癌风险的相关性进行了系统的综述和荟萃分析。数据库的时间范围为2000年1月至2009年12月。最终,有12项,6项和3项研究分别适合进行Arg399Gln,Arg194Trp和Arg280His的荟萃分析。根据最可能合适的遗传模型进行重组。寻找了异质性的潜在来源。对于整体胃癌,Arg399Gln,Arg194Trp和Arg280His的合并比值比为1.04(95%置信区间(CI):0.90,1.20; P = 0.572),0.83(95%CI:0.68,1.01; P = 0.059) ,1.18(95%CI:0.92、1.50; P = 0.194)。在按解剖类型(心脏与非心脏)对Arg399Gln SNP数据进行分层后,合并的优势比为1.07(95%CI:0.84、1.37; P = 0.568)。作者得出的结论是,所评估的3个SNP与胃癌的风险无关。 Arg399Gln SNP与the门癌类型无关。显然,研究中关于Arg399Gln SNP的异质性无法通过种族,基因分型技术,样本量或发表日期来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号